Hogg, Simon J. http://orcid.org/0000-0002-3170-839X
Beavis, Paul A. http://orcid.org/0000-0002-2116-013X
Dawson, Mark A. http://orcid.org/0000-0002-5464-5029
Johnstone, Ricky W. http://orcid.org/0000-0001-7053-9237
Article History
Accepted: 30 June 2020
First Online: 14 September 2020
Competing interests
: The authors declare the following competing interests: the Johnstone laboratory receives funding from Roche, BMS and MecRx. R.W.J is a paid consultant and shareholder of MecRx. M.A.D. has been a member of advisory boards for CTX CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix. S.J.H. and R.W.J. are inventors on a patent (WO2017059319A3) related to combining bromodomain inhibitors and immune-modulating therapies.